METFORMIN IN THE TREATMENT OF HYPERGLYCEMIC CONDITIONS

Details for Australian Patent Application No. 2002322806 (hide)

Owner THE GOVERNEMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT O The Regents of the University of California

Inventors SANTIAGO, Julio; BRAY, George, A.; GOHDES, Dorothy; SCHWARTZ, Robert, S.; SCHADE, David, S.; OLEFSKY, Jerrold, M.; NATHAN, David, M.; MOLITCH, Mark, E.; METZEGER, Boyd, E.; KNOWLER, William, C.; KAHN, Steven, E.; HORTON, Edward, S.; SHAMOON, Harry; FUJIMOTO, Wilfred, Y.; GARFIELD, Sanford, A.

Pub. Number AU-A-2002322806

PCT Number PCT/US02/24225

PCT Pub. Number WO2003/011273

Priority 60/309,194 31.07.01 US

Filing date 30 July 2002

Wipo publication date 17 February 2003

International Classifications

A61P 003/10 Drugs for disorders of the metabolism

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/309,194 31.07.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002322806

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322807-HUB ASSEMBLY WITH DRIVEN HUB

2002322805-Inhibitor of DNA methylation